Literature DB >> 27329733

A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene.

Lance H Rodan1, Julie Cohen2, Ali Fatemi2, Tammy Gillis3, Diane Lucente3, James Gusella3,4, Jonathan D Picker1.   

Abstract

We report compound heterozygous variants in HTT, the gene encoding huntingtin, in association with an autosomal recessive neurodevelopmental disorder. Three siblings presented with severe global developmental delay since birth, central hypotonia progressing to spastic quadraparesis, feeding difficulties, dystonia (2/3 sibs), prominent midline stereotypies (2/3), bruxism (1/3), high myopia (2/3), and epilepsy (1/3). Whole exome sequencing identified compound heterozygous variants in HTT that co-segregated in the three affected sibs and were absent in an unaffected sib. There were no additional variants in other genes that could account for the reported phenotype. Molecular analysis of HTT should be considered, not just for Huntington's disease, but also in children with a Rett-like syndrome who test negative for known Rett and Rett-like syndrome genes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27329733      PMCID: PMC5117927          DOI: 10.1038/ejhg.2016.74

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  Huntington's disease: seeing the pathogenic process through a genetic lens.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Trends Biochem Sci       Date:  2006-07-10       Impact factor: 13.807

2.  Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.

Authors:  J K White; W Auerbach; M P Duyao; J P Vonsattel; J F Gusella; A L Joyner; M E MacDonald
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

3.  The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin.

Authors:  W Auerbach; M S Hurlbert; P Hilditch-Maguire; Y Z Wadghiri; V C Wheeler; S I Cohen; A L Joyner; M E MacDonald; D H Turnbull
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

4.  Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat.

Authors:  Christine M Ambrose; Mabel P Duyao; Glenn Barnes; Gillian P Bates; Carol S Lin; Jayalakshmi Srinidhi; Sarah Baxendale; Holger Hummerich; Hans Lehrach; Michael Altherr; John Wasmuth; Alan Buckler; Deanna Church; David Housman; Mary Berks; Gos Micklem; Richard Durbin; Alan Dodge; Andrew Read; James Gusella; Marcy E MacDonald
Journal:  Somat Cell Mol Genet       Date:  1994-01

5.  Identification of novel genetic causes of Rett syndrome-like phenotypes.

Authors:  Fátima Lopes; Mafalda Barbosa; Adam Ameur; Gabriela Soares; Joaquim de Sá; Ana Isabel Dias; Guiomar Oliveira; Pedro Cabral; Teresa Temudo; Eulália Calado; Isabel Fineza Cruz; José Pedro Vieira; Renata Oliveira; Sofia Esteves; Sascha Sauer; Inger Jonasson; Ann-Christine Syvänen; Ulf Gyllensten; Dalila Pinto; Patrícia Maciel
Journal:  J Med Genet       Date:  2016-01-06       Impact factor: 6.318

6.  Inactivation of the mouse Huntington's disease gene homolog Hdh.

Authors:  M P Duyao; A B Auerbach; A Ryan; F Persichetti; G T Barnes; S M McNeil; P Ge; J P Vonsattel; J F Gusella; A L Joyner
Journal:  Science       Date:  1995-07-21       Impact factor: 47.728

7.  MeCP2: a novel Huntingtin interactor.

Authors:  Karen N McFarland; Megan N Huizenga; Shayna B Darnell; Gavin R Sangrey; Oksana Berezovska; Jang-Ho J Cha; Tiago F Outeiro; Ghazaleh Sadri-Vakili
Journal:  Hum Mol Genet       Date:  2013-10-08       Impact factor: 6.150

8.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Authors:  J-M Lee; E M Ramos; J-H Lee; T Gillis; J S Mysore; M R Hayden; S C Warby; P Morrison; M Nance; C A Ross; R L Margolis; F Squitieri; S Orobello; S Di Donato; E Gomez-Tortosa; C Ayuso; O Suchowersky; R J A Trent; E McCusker; A Novelletto; M Frontali; R Jones; T Ashizawa; S Frank; M H Saint-Hilaire; S M Hersch; H D Rosas; D Lucente; M B Harrison; A Zanko; R K Abramson; K Marder; J Sequeiros; J S Paulsen; G B Landwehrmeyer; R H Myers; M E MacDonald; J F Gusella
Journal:  Neurology       Date:  2012-02-08       Impact factor: 9.910

  8 in total
  20 in total

Review 1.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

2.  Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.

Authors:  Eric Vallabh Minikel; Daniel G MacArthur
Journal:  Neuron       Date:  2016-10-19       Impact factor: 17.173

3.  Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.

Authors:  Aram Shin; Baehyun Shin; Jun Wan Shin; Kyung-Hee Kim; Ranjit S Atwal; Jennifer M Hope; Tammy Gillis; John D Leszyk; Scott A Shaffer; Ramee Lee; Seung Kwak; Marcy E MacDonald; James F Gusella; Ihn Sik Seong; Jong-Min Lee
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

4.  Computational insights into missense mutations in HTT gene causing Huntington's disease and its interactome networks.

Authors:  Muneeza Qayyum Khan; Hira Mubeen; Zohaira Qayyum Khan; Ammara Masood; Asma Zafar; Javed Iqbal Wattoo; Alim Un Nisa
Journal:  Ir J Med Sci       Date:  2022-07-13       Impact factor: 2.089

Review 5.  Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities.

Authors:  Sarah J Tabrizi; Carlos Estevez-Fraga; Willeke M C van Roon-Mom; Michael D Flower; Rachael I Scahill; Edward J Wild; Ignacio Muñoz-Sanjuan; Cristina Sampaio; Anne E Rosser; Blair R Leavitt
Journal:  Lancet Neurol       Date:  2022-07       Impact factor: 59.935

6.  Mutations causing Lopes-Maciel-Rodan syndrome are huntingtin hypomorphs.

Authors:  Roy Jung; Yejin Lee; Douglas Barker; Kevin Correia; Baehyun Shin; Jacob Loupe; Ryan L Collins; Diane Lucente; Jayla Ruliera; Tammy Gillis; Jayalakshmi S Mysore; Lance Rodan; Jonathan Picker; Jong-Min Lee; David Howland; Ramee Lee; Seung Kwak; Marcy E MacDonald; James F Gusella; Ihn Sik Seong
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

7.  Cell-type and fetal-sex-specific targets of prenatal alcohol exposure in developing mouse cerebral cortex.

Authors:  Nihal A Salem; Amanda H Mahnke; Kranti Konganti; Andrew E Hillhouse; Rajesh C Miranda
Journal:  iScience       Date:  2021-04-20

Review 8.  Huntington's Disease Pathogenesis: Two Sequential Components.

Authors:  Eun Pyo Hong; Marcy E MacDonald; Vanessa C Wheeler; Lesley Jones; Peter Holmans; Michael Orth; Darren G Monckton; Jeffrey D Long; Seung Kwak; James F Gusella; Jong-Min Lee
Journal:  J Huntingtons Dis       Date:  2021

Review 9.  Huntington's disease: nearly four decades of human molecular genetics.

Authors:  James F Gusella; Jong-Min Lee; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

10.  Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype.

Authors:  Mario Lucariello; Enrique Vidal; Silvia Vidal; Mauricio Saez; Laura Roa; Dori Huertas; Mercè Pineda; Esther Dalfó; Joaquin Dopazo; Paola Jurado; Judith Armstrong; Manel Esteller
Journal:  Hum Genet       Date:  2016-08-19       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.